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Abstract
India ranks high for prevalence of diabetes and the treatment of diabetes without any side
effects  is  still  challenging.  Though  herbal  remedies  help  reduce  the  side  effect,  proper
standardization of phytochemical which prove as a bioactive compound, its proper dose
and clinical trials are lacking. In our investigation, we studied the binding mechanism of the
secondary  metabolites  of  Syzygium  cumini,  their  in  vitro antidiabetic  activity  and  the
number of phytochemicals present. In silico study revealed that ellagic acid has a potential
to modulate the carbohydrate metabolizing enzyme activity showing higher affinity for the
enzymes with much lesser binding energy, -4.73 kcal/mol for alpha amylase, -4.87 kcal/mol
for  beta-glucosidase,  -4.79  kcal/mol  for  glycogen  synthase  kinase,  -4.18  kcal/mol  for
glucokinase  and  -4.49  kcal/mol  for  alpha-glucosidase.  In  vitro-Alpha  amylase  inhibitory
activity  assay  showed  that  ethanol  extract  has  the  highest  value  of  percent  inhibition
(73.33%) as compared to standard drug Acarbose (65.99%). Finally, TLC analysis cleared that
ethanol extract contains five compounds one of which may be a bioactive compound, ellagic
acid. Further purification and characterization of the ellagic acid is needed.
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Introduction
India  is  known  as  the  “Diabetes  capital  of  the
world” with high prevalence of diabetes (more than
62  million)  in  the  country.  Every  fifth  diabetes
patient  occurs  in  the  world  is  an  Indian.  It  is
estimated that,  in India up to 79.4 million people
will affect adversely with diabetes by 2030 (Joshi et
al., 2007; Kaveeshwar  et al.,  2004). The two major
types  of  diabetes  viz.  Type  I  diabetes  (T1D),  an
autonomous disease cause due to insufficient or no
production  of  insulin  in  the  body  and  Type  II
diabetes  (T2D)  in  which  progressive  insulin
resistance  is  developed.  Out  of  these,  type  I
accounts  only  for  10-15% incidence  while  that  of
type  II  for  85-90%.  Type  II  diabetes  has  a  higher
dominance  worldwide  and  is  a  serious  growing
public  health  problem.  Apart  from  the  health
consequences,  diabetes  is  one  of  the  economic
burdens,  including cost of treatment of the disease
and  its  associated  complications,  increased
mortality and morbidity cost and the cost required
for informal care etc. (Hex et al., 2012).
T2D is predominant in the individual of age
40 or above 40, hence also considered  as a  disease 
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of  middle-aged  and  elderly  (Singh,  2011;
Ozougwu  et  al., 2013).  It  is  a  multifactorial
disease  involving  various  genetic  as  well  as
environmental  risk  factors  responsible  for  the
disease. It is a hereditary disease can cause due
to  sedentary  lifestyle,  alcohol  drinking,
smoking, aging, obesity, etc. (Kohei  et al.,  2010;
Mehta  et  al.,  2009).  If  untreated  or  not
diagnosed  at  early  stages,  it  leads  to  various
complications  that  finally  results  in  morbidity
and  mortality.  Infections,  hypertension,  limb
amputations,  dyslipidemia,  renal  failure,
blindness  are  some  of  the  complications  arise
due to the T2D. Treatment for the T2D includes
proper  diet  and  exercise,  administration  of
hypoglycemic  agents.  Pharmacological
treatments  are  also  effective  in  reducing  the
risk  (DiStefano  et  al.,  2010;  Bastaki  2005).
Herbal  remedies  are  found  to  be  effective  in
order to minimize the side effects arising from
the  oral  hypoglycemic  agents.  Bioactive
potential  present  in  the  plants  is  due  to  the
presence  of  various  phytochemicals  such  as
alkaloids,  phenolics,  flavonoids,  tannins,
terpenoids etc.  (Rao  et  al.,  2010).  Today 21,000
medicinal plants are listed by the World Health
Organization (WHO) among which 2500 species
are of Indian origin.  Proper standardization of
the  phytochemicals  present,  biological  activity
profile as well as their proper doses and clinical
trials is of greatest interest so as to achieve the
target  of  phyto-pharmaceutical  market
(Kamboj, 2000; Peixoto et al., 2013).
Syzygium cumini or Eugenia jambolana is
originated  from  India  and  is  very  often
cultivated.  It  is  also  known  as  Indian
Blackberry or Jamun. Apart from India it is also
found  in  the  Philippines,  Thailand  (Sharma  et
al.,  2006),  South  Asia,  Pakistan,  Sri  Lanka,
Nepal,  Bangladesh,  Indonesia,  Burma  etc.
(Ayyanar  et  al.,  2012).  It  is  a  rich  source  of
phytochemicals such as alkaloid like jambosine
(Ayyanar  et  al.,  2012),  ellagic  acid,  terpenoids,
kaempferol,  myricetin,  quercetin,  isoquercitin
(Afify et al., 2011), gallic acid, jamboline as well
as some anthocyanins like malvidine glucoside,
petunidin, cyaniding etc. (Raza et al., 2015). Out
13.5  million  tones  of  worldwide  production  of
jamun  India  rates  highest  with  15.4%  of  total
production  (Raza  et  al.,  2015).  Due  to  the
presence of a variety of secondary metabolites,
the  plant  shows  diverse  biological  activities.
Hydroalcoholic  leaf  extract  shows  effective
antibacterial activity against various pathogens,
including  multidrug  resistant  strains  of
Staphylococcus  aureus and  Pseudomonas
aeruginosa (Oliveira  et  al.,  2007).  Seed kernels
extract in combination with the Acarbose found
to  be  very  effective  in  preventing  the
development  of  diabetes  induced  ulcerogenic
stimuli  (Jonnalagadda  et  al., 2013).  Apart  from
this  Syzygium  cumini  posses  other
pharmacological  activities  like  anti-
hyperglycemic  activity,  cardioprotective
activity,  anti-inflammatory activity,  antioxidant
activity  etc.  (Chagas  et  al., 2015).  -sitosterolɣ
and  Kaempferol  7-Omethylether  isolated  from
an  ethanol  extract  of  S.  cumini fruit  possesses
antioxidant  and  anticancer  activities
(Sharafeldin  et al,.  2015).  Anthocyanin isolated
from the  fruit  and  pulp  has  shown anticancer
activity  against  the  early  stage  of  HCT-116
human colon cancer cells.  It  induces apoptosis
as  well  as  inhibits  self-renewal  property  of
colon cancer stem cells (colon CSCs) (Charepalli
et  al.,  2016).  Not only fruit  and seed but other
parts  of  the  S.  cumini have  proven  to  be  a
medicinally  important  properties.  Aqueous
extract  of  leaves  and  bark  possess  antiviral
activity  against  avian  influenza  (H5N1)  virus
(Sood et al., 2012).
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Table 1.  Binding energies kcal/mol obtained during docking analysis of secondary metabolites found in  S. cumini
with their target enzymes
Sl.
No.
Compounds Alpha-amylase Beta-glucosidase Glycogen 
synthase 
kinase-3β
Glucokinase Alpha-
Glucosidase
1 Caffeic acid -3.43 -3.63 -4.59 -3.74 -3.22
2 1-galloyl glucose -1.19 -2.67 -1.52 -1.82 -2.15
3 Corilagin -1.73 -2.09 -1.15 -1.2 -1.00
4 Ellagic acid -4.73 -4.87 -4.79 -4.18 -4.49
5 Ferulic acid -3.01 -3.34 -4.46 -2.51 -3.19
6 Gallic acid -3.12 -2.63 -3.79 -3.33 -3.44
7 Guajacol -3.54 -3.24 -3.00 -2.77 -3.21
8 Quercetin -3.42 -4.69 -4.34 -3.68 -3.48
9 Veratrol -3.16 -3.17 -2.98 -3.05 -3.09
10 Acarbose -0.46 -2.72 -2.66 -1.87 -2.05
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Herbal  medicines  to  cure  diabetes
mellitus are always preferred because of its less
or no side effect. Considering this view, we have
designed  the  study  to  check  the  antidiabetic
potential  of  the  plant  S.  cumini using  in  silico
and in vitro approach and the possible bioactive
compound was also studied.
Materials and Methods
In silico approach
Molecular docking
The structure of the target proteins in PDB format
was  retrieved  from  a  crystallographic  database
(www.rcsb.org/pdb/). PDB file of different enzyme
structures  viz. Human  pancreatic  alpha  amylase
(PDB ID: 1HNY), Human cytosolic beta glucosidase
(PDB ID: 2JFE), Human glycogen synthase kinase-
3β (PDB ID: 4ACD),  Human Glucokinase (PDB ID:
1V4T),  Sugar  beet  alpha-glucosidase  (PDB  ID:
3W37), were downloaded. 
According  to  the  literature  (European
Agency for the Evaluation of Medicinal Products)
nine major secondary metabolites are found in the
seed part of the S. cumini as shown in the Table 1.
The  structure  of  all  nine compounds  was  mined
from the PubChem database in their SDF format
and  considered  as  a  ligand.  These  ligands  then
converted  into  Pdbqt  format  using  Open  Babel,
which is a suitable file format for docking in PyRx. 
All  the  ligands  were  then  subjected  to
energy  minimization  followed  by  docking
analysis  using  Autodock  module  available  in
the  PyRx  Version  0.8  software
(http://pyrx.sourceforge.net/). Total 10 conformers
of  each  ligand  molecule  were  analyzed  to
predict  the  most  favorable  interaction.  Finally
docking  interaction  of  the  docked  compounds
with  its  protein  was  analyzed  using  LigPlot
software  (https://www.ebi.ac.uk/thornton-
srv/software/LIGPLOT/).
In vitro approach
Plant material and extract preparation
S.  cumini seeds  were  collected  from a  region  of
Ahmednagar (MS), India and authenticated by the
Department  of  Botany,  Padmashri  Vikhe  Patil
College, Pravaranagar (Loni),  Tal.  Rahata,  District
Ahmednagar, (MS), India. Seeds were ground into
fine  powder  and  were  successively  extracted  by
maceration  in  petroleum  ether,  chloroform,
ethanol  and  aqueous  (increasing  order  of  their
polarity).  Solvent  containing  extract  was
evaporated to  obtain dry crude  extracts.  Percent
yield of the extract in each solvent was calculated
(Okoro et al., 2014).
In vitro alpha amylase inhibitory activity assay
The  assay  was  performed  according  to  simple
modification  of  Narkhede  et  al.,  2011  method.  A
volume of 250 μl of the test samples and different
concentrations  of  standard  drug  i.e. 100-1000
μg/ml  were  mixed  with  250  μl  of  0.20mM
phosphate buffer (pH 6.9) and alpha amylase (0.5
mg/ml  in  0.02M  phosphate  buffer,  pH-6.9  with
0.006M  Sodium  Chloride),  pre-incubated  the
mixture at 25°C for 10 min. 250 μl of a 1% starch
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Fig 1. (a) Hydrophobic and hydrophilic interactions of ellagic acid with beta glucosidase residues. Brown
colored half circle indicates the hydrophobic reactions of ellagic acid with the enzymes. Green dotted
lines indicate the hydrogen bond along with their bond length. (b) Best binding mode of ellagic acid with
beta glucosidase enzyme.
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solution (in 0.02 M sodium phosphate buffer, pH
6.9)  was  added to  each tube  containing  reaction
mixture and again incubated at 25°C for 10 min.
The reaction was then terminated with 500  µl  of
DNSA (3, 5 dinitrosalicylic acid, a chromogen) and
product  formed  were  analyzed  by  boiling  the
mixture  in  boiling  water  bath  for  5  min.  Tubes
were cooled at room temperature and diluted the
solution with 5 ml of distilled water. Intensity was
measured  at  540nm.  Control  represent  100%
enzyme  activity,  prepared  using  the  same
procedure  replacing  the  extract  with  distilled
water (Narkhede et al., 2011).
The  α-amylase  inhibitory  activity  was
calculated  by using following formula and IC50
value was determined graphically:
% Inhibition = [(Abscontrol-Absextracts)/Abscontrol] x 100
Chromatographic separation
The  presence  of  the  bioactive  compounds  was
determined  by  Thin  Layer  Chromatography.
Chromatoplates  were  prepared  on  microscope
slide by mixing silica gel and distilled water in 1:2
ratios  at  a  uniform  thickness  of  0.5mm.  Plates
were then dried and were activated in an oven at
1100C for 1hr. 10 µl of the extract was spotted on a
chromatoplate,  dried  and  allowed  to  develop  a
chromatogram  with  the  help  of  an  appropriate
solvent  shown  in  Table  3.  Developed
chromatogram  was  observed  by  using  iodine
vapor (Singh et al., 2005). Rf value was calculated
using following formula:
Rf  =  Distance  travelled  by  solute  (cm)  /Distance
travelled by solvent (cm) 
Result and Discussion
In silico - molecular docking analysis
Molecular  docking  analysis  of  the  secondary
metabolites  found  in  the  S.  cumini with  the
major  enzymes  those  incorporate  into  the
diabetes  mellitus  were  performed  to  gain
insight into the potential antidiabetic activity of
these  compounds.  The  binding  mode  and  the
favorable  docking  interaction  of  the  selected
secondary metabolites were analyzed based on
the  binding  energies  obtained  by  the  docking
results  (Ganugapati  et  al.,  2012).  Docking
reveals the proper orientation of ligand–protein
complex  as  well  as  various  potential  binding
sites  (Mobley  et  al., 2009).  The  docking  result
with  their  binding  energies  is  shown  in  the
Table  1  while  the  Figure  1(b)  and  Figure  3
indicate the most favorable binding mode of the
compounds.  Out of nine secondary metabolites
studied  Ellagic  acid  shown  higher  affinity  for
the enzymes with much lesser binding energy ,
-4.73 kcal/mol for alpha amylase, -4.87 kcal/mol
for beta-glucosidase, -4.79 kcal/mol for glycogen
synthase kinase,  -4.18 kcal/mol  for glucokinase
and -4.49 kcal/mol  for alpha-glucosidase (Table
1). More or less ellagic acid have shown an anti-
diabetic  potential  against  all  enzymes  studied
but  comparing  in  between  them,  beta-
glucosidase  shows  highest  binding  affinity.
Considering  this  the  further  interaction  of  the
enzyme  is  studied  in  order  to  understand  the
proper  orientation  and  interaction.  There  are
two  active  site  residues  of  beta-glucosidase
enzyme that plays a crucial role in the enzyme
catalyzed  reaction  viz.  Tyr315  and  Glu440
(Badieyan et al., 2012). Favorable binding of the
ellagic  acid  to  the beta-glucosidase  reveals  the
‘novel’  binding  site  residues  that  can  play
important  role  in  binding  and  interactions  of
drugs  with the enzyme. Some of these binding
site  residues  such  as  Val68,  Phe121,  Phe179,
Phe225,  Trp345,  Trp425,  Asn426,  Gln427
interact  with  hydrophobic  interactions  while
others  like  Glu  165  interact  with  hydrogen
bonding (Figure 1 (a)). Hydrogen bond distance
of the Glu 165 residue is 2.84A0. Considering the
hydrogen  bonding  interaction  of  the  other
enzymes,  alpha  amylase  forms  total  two
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Table 2. Alpha amylase inhibition by S. cumini using different solvent extracts. Tests were carried out in triplicate
manner and values are expressed as the mean ± SD. The IC50 value is the concentration of inhibitor which inhibits
50% of its activity under the assayed conditions. (SCPE-S. cumini petroleum ether extract, SCCE- S. cumini chloroform
extract, SCEE- S. cumini ethanol extract, SCAE- S. cumini aqueous extract)
Sr.
No.
Concentration 
(µg/ml)
% Inhibition
Acarbose SCPE SCCE SCEE SCAE
1 100 42.15 ± 0.68 15.90 ± 3.09 21.88 ±0.31 35.12 ±0.19 33.69±5.77
2 200 57.88 ± 2.42 17.03 ± 2.63 23.40 ±2.35 40.80 ±5.36 34.35±5.62
3 400 62.24 ± 0.53 19.02 ± 0.57 25.24 ±2.19 56.62 ±5.41 36.00±4.98
4 600 63.76 ± 0.96 19.64 ± 0.16 25.89 ±2.26 61.15 ±5.96 36.22±4.74
5 800 64.66 ± 1.26 20.98 ± 0.81 28.37 ±0.63 69.62 ±0.09 38.61±4.68
6 1000 65.99 ± 1.76 23.41 ± 2.10 29.85 ±0.82 73.33 ±0.16 42.90±2.49
IC50 values (µg /ml) 52 4497 3365 374 1932
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hydrogen bonds  Lys  178  and His  185  with the
bond  distance  2.99  A0 and  2.86A0 respectively
(Figure  2(A)),  Glycogen  synthase  kinase  forms
total four hydrogen bonds out of which two are
from B chain of Lys 205 with bond distance 3.10
A0 and 3.22 A0  while other two are from Val 214
(chain  B)  and  Lys  292  (chain  A)  with  bond
distance 3.31 A0 and 3.17 A0 respectively (Figure
2(B)).  Glucokinase  forms  only  one  hydrogen
bond  with  Asn  204  of  A  chain  and  the  bond
distance  is  3.13  A0  (Figure  2(C)).  Finally  alpha
glucosidase forms three hydrogen bonds from A
chain  residue.  Arg720  forms  a  hydrogen  bond
with  bond  distance  3.32  A0  while,  Gly738  with
bond distance 3.14 A0 and 3.16 A0 (Figure 2 (D). 
Out  of  five  enzymes  studied  in  silico,
which  showed  favorable  interactions  with  all
secondary  metabolites  from  S.  cumini,  alpha
amylase  inhibition  is  a  potent  weapon against
the  diabetes  as  it  reduces  the  breakdown  of
complex  carbohydrates,  thereby  lowering  the
levels of postprandial hyperglycemia (Alagesan
et al., 2012a).  Therefore,  we have screened the
different  solvent  plant  extracts  for  their
significant  alpha  amylase  inhibitory  activity
which can give an idea about the extract which
shows  the  highest  potential  containing  a
bioactive substance in it specifically above said
compound i.e. ellagic acid. 
In  vitro  -  alpha  amylase  inhibitory  activity
analysis
Decreasing post- prandial blood glucose level is
one of the therapeutic approaches used to treat
the  Diabetes  mellitus  (Khacheba  et  al.,  2014).
This  can be  achieved  by  using  some  starch  or
carbohydrate blockers that delay the process of
carbohydrate  hydrolysis  and  absorption  and
thereby decreasing the postprandial increase of
blood  glucose  after,  a  starch  or  mixed
carbohydrate diet (Sales et al., 2011; McEwan et
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Fig 2. Hydrophobic interactions and hydrogen bonds of ellagic acid with amino acid residues of A. Alpha
amylase,  B. Glykogen synthase kinase,  C.Glucokinase D.  Alpha glucosidase.  Brown colored half  circle
indicates the hydrophobic reactions of ellagic acid with the enzymes. Green dotted lines indicate the
hydrogen bond along with their bond length. 
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al.,  2010).  In  order  to  confirm  antidiabetic
effect of all nine secondary metabolites from S.
cumini  by  the  inhibition  of  alpha  amylase,  we
studied  in  vitro the  effect  of  these
phytochemicals on the activity of alpha amylase
at  varying  concentration  of  plant  extracts,  to
identify the minimum concentration (IC50) with
the  inhibitory  ability  on  the  enzyme.  The
results  obtained  were  compared  with  the
standard drug Acarbose as a control.  Standard
drug  showed  the  highest  percent  inhibition
65.99  ±  1.76  at  the  concentration  of  1mg/ml
comparing with other plant extracts at the same
concentration,  SCPE  showed  the  highest
inhibition at 23.41 ± 2.10, SCCE showed highest
percent inhibition at 29.85 ±0.82,  SCEE showed
highest  percent inhibition at  73.33 ±0.16 while
SCWE showed the highest percent inhibition at
42.90±2.49 (Table 2).
Among  all  extracts,  ethanol  extract  of
the  S.  cumini has  highest  value  of  percent
inhibition.  The peak is  higher  than that  of  the
standard showing its potential in inhibiting the
activity  of an enzyme (Graph 1)  and minimum
inhibitory  concentration  (IC50)  as  374(µg  /ml).
The  alpha  amylase  inhibitory  activity  of  the
plant  extract  is  due  to  the  presence  of
secondary  metabolites  present  in  it  (Uddin  et
al., 2014). Seed and leaf extract of S. cumini also
reported  to  have  a  α-Glucosidase  inhibitory
activity and this activity is due to the presence
of  secondary  metabolites  apigenin  7-O-
glucoside  and  dihydro-3,3’,4’,5,7  –
pentahydroxyflavone  glycoside  respectively
(Alagesan et al., 2012b).
TLC profiling
TLC profiling is a  crucial  technique to identify
active compound from a plant extracts (Simões-
Pires et al., 2009). With very minute analyte and
short time span it provides effective separation
of  the  active  compound  revealing  the  number
of compounds present in that plant (Kamalakar
et  al.,  2014).  Table  3  shows  the  result  of  TLC
analysis.  Different  solvent  system  dissolves
different  secondary  metabolites,  therefore  the
solvent  system  for  each  extract  is  selected  in
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Fig  3.  Best  binding  mode  of  ellagic  acid  with  A.  Alpha  amylase,  B.  Glykogen  synthase  kinase,
C.Glucokinase D. Alpha glucosidase. 
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such a way that it might give a better separation
of a particular compound. In our investigation,
it  is  clear  that  in  solvent  system  chloroform:
ethyl  acetate  (3:1),  petroleum  ether  extract
shows  two  spots  with  Rf  values  0.96,  0.58.  In
solvent  system  chloroform:  ethyl  acetate  (4:6),
chloroform  extract  shows  two  spots  with  Rf
values  0.83,  0.63.  In  solvent  system  ethyl
acetate:  methanol:  water  (5:1.1:1),  ethanol
extract  shows  total  five  spots  with  Rf  values
0.93,  0.75,  0.46,  0.39,  0.26.  Finally,  in  solvent
system  toluene:  ethyl  acetate  (4:1),  aqueous
extract  shows  two  spots  with  Rf  values  0.85,
0.17.  Comparing  the  result,  it  is  clear  that
ethanol  extract  contains  more  compounds
concluding  that  might  contain  a  biologically
active  compound  which  shows  potent
antidiabetic activity.
Conclusion
It is clear from the overall investigation that all the
secondary  metabolites  present  in  the  S.  cumini
shows antidiabetic potential.  In silico analysis has
contributed in finding that ellagic acid present in
the  seed  has  a  great  capacity  to  modulate  the
enzyme action, hence proves a biologically active
compound. In vitro alpha amylase inhibition assay
gives  an  idea  about  the  extract  and  a  required
concentration (IC50)  that  has greater capability to
inhibit an enzyme action and thereby reducing the
glucose level. Finally, in TLC cleared that ethanol
extract contains various compounds, one of which
possessing  potent  antidiabetic  activity.  But  still
further  investigation  is  required  to  confirm  the
bioactive  property  of  ellagic  acid  by  purifying  it
from  the  extract  and  subjecting  to  the  in  vitro
alpha amylase inhibitory analysis.
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Graph 1. The enzyme inhibitory activity of different extracts of S. cumini seeds on α-amylase 
Table 3. TLC result of different extracts of S. cumini visualized by iodine chamber
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No
Extract Solvent system used Rf value
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